Hudson Bay Capital Management LP Amgen Inc Transaction History

Hudson Bay Capital Management LP

$18.6 Billion
Q2 2024

A detailed history of Hudson Bay Capital Management LP transactions in Amgen Inc stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 10,000 shares of AMGN stock, worth $3.23 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

10,000

Previous 114,400 91.26%

Holding current value

$3.23 Million

Previous $32.5 Million 90.4%

% of portfolio

0.02%

Previous 0.2%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $27.4 Million - $33.3 Million	-104,400 Reduced 91.26%	10,000 $3.12 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $14.6 Million - $17.7 Million	54,400 Added 90.67%	114,400 $32.5 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $15.3 Million - $17.3 Million	60,000 New	60,000 $17.3 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $36 Million - $42.6 Million	168,000 Added 3360.0%	173,000 $38.4 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $45.8 Million - $55.8 Million	-202,900 Reduced 97.59%	5,000 $1.21 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $47.6 Million - $60.5 Million	207,900 New	207,900 $54.6 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $2.15 Million - $2.46 Million	-10,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $2.29 Million - $2.69 Million	10,800 New	10,800 $2.3 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $452,175 - $509,700	-2,500 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $446,000 - $520,625	2,500 New	2,500 $487,000
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $2.79 Million - $3.13 Million	-16,800 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $2.85 Million - $3.33 Million	16,800 New	16,800 $2.86 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Amgen Inc Transaction History